3rd Cell Therapy for Autoimmune Disease Summit
December 2-4, 2025
Philadelphia, PA
Over the past few weeks, we have seen top biopharma and academic leaders mark their calendars for the 3rd Cell Therapy for Autoimmune Disease Summit – including large teams from Cabaletta Bio, Novartis, Legend Biotech and the University of North Carolina at Chapel Hill.
These major players have demonstrated their commitment to autoimmunity, now it’s your turn.
Register now to take advantage of a 10% discount with code 58605AA10: https://ter.li/svp4uz
A Preview of What is Awaiting You:
- Featuring an 80% new speaker faculty, gain fresh perspectives into autoimmune cell therapy assay development, antibody and cell targeting, treatment persistence and patient recruitment.
- Hear the latest insights and clinical readouts from 11 new companies including Orbital Therapeutics, PolTREG, Nkarta Therapeutics, Overland Pharmaceuticals and more.
- Our tracked format will now extend to the workshop day, allowing you to enjoy 3 days of tailored learning to accelerate progression from discovery through to clinical trials.
Together let’s unite in the goal of translating cell therapy clinical promise into real autoimmune breakthroughs!